insights_auto
Why is DEVA down 2.46%?
Dive Deeperchevron_right
DEVA:IST
Deva Holding AS
TRY 87.35
arrow_downward
-2.46%(-2.20) 1D
Oct 6, 6:10:00 PM GMT+3 · TRY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DEVA...
Open
TRY 88.60
High
TRY 89.80
Low
TRY 87.10
Mkt. cap
17.44B
Avg. vol.
762.36K
Volume
204.65K
52-wk high
TRY 109.30
52-wk low
TRY 57.50
EPS
-TRY 4.21
Shares outstanding
200.02M
No. of employees
3K
Open
TRY 88.60
High
TRY 89.80
Low
TRY 87.10
Mkt. cap
17.44B
Avg. vol.
762.36K
Volume
204.65K
52-wk high
TRY 109.30
52-wk low
TRY 57.50
EPS
-TRY 4.21
Shares outstanding
200.02M
No. of employees
3K
News stories
From web sources and news partners
www.marketscreener.com
·
1 hour ago
S&P 500 index edged lower after Stockholm market close on Tuesday
UA.NEWS
·
8 hours ago
S&P 500 and Nasdaq finish trading at record levels — Anadolu Agency
BigGo Finance
·
3 hours ago
S&P 500 Sets Another Record, but Bitcoin's Fate Hinges on Yields and Dollar
Profile
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
About Deva Holding AS